Metraipolis › archive › dc_db05b4ae320d

The benefit of deep genomic testing for asymptomatic high-risk individuals undergoing surveillance for pancreatic adenocarcinoma: European registry for… — Europe PMC PMID:42361786

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42361786
DOI
10.1016/j.neo.2026.101316
License (as archived)
solo-consultazione
Archived
2026-11-01T09:54:45.004Z
SHA-256 of the archived text
d7f5b8dc8d22b972211dfcc529cc3431e390ff2f73adaa92f7e0050fcbe80659
Stable URL of this page
https://metraipolis.com/documento/dc_db05b4ae320d

How to cite

The benefit of deep genomic testing for asymptomatic high-risk individuals undergoing surveillance for pancreatic adenocarcinoma: European registry for… — Europe PMC PMID:42361786 — Europe PMC (en), https://europepmc.org/article/MED/42361786 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_db05b4ae320d (Metraipolis archive dc_db05b4ae320d, sha256 d7f5b8dc8d22b972211dfcc529cc3431e390ff2f73adaa92f7e0050fcbe80659)
BibTeX
@misc{dcdb05b4ae320d,
  title = {The benefit of deep genomic testing for asymptomatic high-risk individuals undergoing surveillance for pancreatic adenocarcinoma: European registry for… — Europe PMC PMID:42361786},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42361786},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_db05b4ae320d; sha256 d7f5b8dc8d22b972211dfcc529cc3431e390ff2f73adaa92f7e0050fcbe80659},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42361786. Agents can read the archived copy with the MCP tool read_document.